Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Smoking Cessation Aids

Published by: Global Industry Analysts

Published: Jan. 1, 2007 - 210 Pages


Table of Contents


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definition and Scope of Study

Smoking Cessation Aids

Definitions

A. Nicotine Gum

B. Nicotine Patch

C. Nicotine Lozenges And Tablets

D. Others

Nicotine Inhaler

Nicotine Nasal Spray

II. EXECUTIVE SUMMARY

1. Industry Outlook

Current and Future Analysis

Leading Players

Tobacco Products Industry: An Introduction

Regulations/Taxes

Black Market

Cigarette: The Tobacco King

Cigars: All Rolled Up

Glut of Products Restrain Growth

Major Cigar Tobacco Producing Regions

China Dominates the Cigarettes Sector

Competitive Scenario

Table 1: World Cigarettes Market for 2004 & 2005: Market Shares Based on Volume Sales of Leading Manufacturers for Philip Morris, British American Tobacco, Japan Tobacco, Imperial Tobacco, Gallaher, Reynolds American and Others (includes corresponding Graph/Chart)


Table 2: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Billion Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)


Table 3: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)

Table 4: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2000 2006 and 2010 (includes corresponding Graph/Chart)

Table 5: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Why to Quit Smoking

Secondhand Smoke

Why Smoking is Hard to Quit

Methods of Smoking Cessations

Cold Turkey

Drug Therapies

Other Interventions

Benefits of Quitting Smoking

2. World Smoking Statistics

3. Product Overview

Smoking Cessation Aids Defined

Nicotine Gum

Factors to Consider

Effectiveness of Nicotine Gum

Nicotine Patch

Factors to Consider

Nicotine Lozenges & Tablets

Factors to Consider

Other Smoking Cessation Aids

Nicotine Inhaler

Factors to Consider

Nicotine Nasal Spray

Factors to Consider

Non-Nicotine Based Medications

4. Trends and Issues

Strict Regulations Deter Smoking Cessation Aids

Growing Anti Smoking Campaigns

Health Concerns

Corporations Initiate for Smoke Free Work Environment

Television Advertisements - Most Effective Media for Smoking Cessation

Public Awareness through Internet

Rising Prices of Tobacco - A Key Strategy for Quitting Smoking

5. Product Innovations/Introductions

Acomplia to Enter Smoking Cessation Market

Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US Market

Nicødrops Unveils New Lozenge for Smoking Cessation

Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan

Glaxo Unveils First Anti-Smoking Medicine in India

6. Recent Industry Activity

Johnson & Johnson to Take-Over Pfizer Consumer Healthcare

Pfizer Receives FDA Approval for Smoking Cessation Medicine Chantix™

Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum

Pfizer Receives Chinese Approval for Clinical Trials on Smoking Cessation Aid

Pfizer Receives EC Approval for New Varenicline

Formation of Sanofi-Aventis

AXIA Health Management Acquires Smoking Cessation Website

Nicodrops Receives EC Approval for Smoking Cessation Aid

Nabi Unveils Successful Phase II Results for Smoking Cessation Vaccine

FDA Grants Approval for High Strength Bupropion

Watson Pharmaceuticals Receives Rights to Market Zyban®

Pfizer Merges with Pharmacia

FDA Approves Anti-Smoking Medication for OTC Sales

GSK and Taisho to Develop Anti-Smoking Medication

Johnson & Johnson Acquires Alza

7. Focus on Select Global Players

GlaxoSmithKline Plc (UK)

Johnson & Johnson Inc. (USA)

Novartis Consumer Healthcare Inc. (USA)

Perrigo Company (USA)

Pfizer Inc. (USA)

8. Global Market Perspective

Table 6: World Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region - US, Canada, Europe and Rest of World Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 7: World 10-Year Perspective for Smoking Cessation Aids by Geographic Region - Percentage Break down of Dollar Sales for US, Canada, Europe and Rest of the World for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Outlook

Cigarette Smoking is Declining in the US

Smoking Women are at High Risk

Tobacco Companies Spend Big on Advertising

NRT - A Peer into the Past

Popular NRT Brands in the US Market

Table 8: Leading NRT Brands in the US Market by Product Type in 2005: Sales in US$ Millions for Nicorette, Nicoderm CQ, Commit and Other Brands & Private Labels (includes corresponding Graph/Chart)

Product Launches/Developments

Strategic Corporate Developments

Key Players

Johnson & Johnson Inc

Novartis Consumer Healthcare Inc

Perrigo Company

Pfizer Inc

B. Market Analytics

Table 9: US Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)


Table 10: US 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

2. Canada

A. Market Analysis

Outlook

B. Market Analytics

Table 11: Canadian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 12: Canadian 10-Year Perspective for Smoking Cessation aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3. Europe

A. Market Analysis

Outlook

Analysis by Geographic Region

Analysis by Product Segment

Strategic Corporate Developments

Key Players

Cedar Health Ltd. (UK)

Fertin Pharma A/S (Denmark)

GlaxoSmithKline Plc (UK)

Pierre Fabre Laboratories (France)

Sanofi-Aventis (France)

B. Market Analytics

Table 13: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region - France, Germany, UK, Italy, Spain & Rest of Europe Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)


Table 14: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 15: European 10-Year Perspective for Smoking Cessation Aids by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Table 16: European 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3a. France

A. Market Analysis

Outlook

B. Market Analytics

Table 17: French Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 18: French 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3b. Germany

A. Market Analysis

Outlook

B. Market Analytics

Table 19: German Recent Past, Current & Future Analysis for Smoking Cessation aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
Table 20: German 10-Year Perspective for Smoking Cessation aids by Product Segment - Percentage Breakdown of Value Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets for 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3c. The United Kingdom

A. Market Analysis

Outlook

Table 21: Leading OTC-NRT Brands by Company in the UK in 2005: Percentage Breakdown of Value Sales for Nicorette, Niquitin CQ, Nicotinell and Others (includes corresponding Graph/Chart)

Table 22: NRT Advertisement Expenditure by Leading Companies in the UK in 2005: Percentage Breakdown for Pfizer, GlaxoSmithKline, Novartis and Others (includes corresponding Graph/Chart)
B. Market Analytics

Table 23: UK Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)


Table 24: UK 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3d. Italy

A. Market Analysis

Outlook

B. Market Analytics

Table 25: Italian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 26: Italian 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3e. Spain

A. Market Analysis

Outlook

B. Market Analytics

Table 27: Spanish Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 28: Spanish 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

3f. Rest of Europe

A. Market Analysis

Outlook

B. Market Analytics

Table 29: Rest of Europe Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 30: Rest of Europe 10-Year Perspective for Smoking Cessation Aids by Product Segment - Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

4. Rest of World

A. Market Analysis

Outlook

Smoking Statistics in China

Barriers to Promote Smoking Cessation in the Developing World

Economic Factors

Inadequate Policies to Support Cessation

Low Perception of Risk among Public and Policy Makers

Poor Healthcare Systems and Infrastructure

Lack of Technology

Strategic Corporate Developments

Product Launches

Sigma Pharmaceuticals Pty Ltd. (Australia) - A Key Player

B. Market Analytics

Table 31: Rest of World Recent Past, Current & Future Analysis for Smoking Cessation Aids - Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. Biovail Corporation (Canada)

Table 32: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 33: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 34: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Biovail Pharmaceuticals (Canada)

2. Blue Whale LLC/Blue Whale Smokeless (USA)

3. Bravo Smokes Corporation (USA)

4. Bulgarian Pharmaceutical Group Ltd. (Bulgaria)

5. Cedar Health Ltd. (UK)

6. Cirrus Healthcare Products LLC (USA)

7. D&E Pharmaceuticals, Inc. (USA)

8. Dipstop (USA)

9. Eyefive, Inc. (USA)

10. E-Z Quit, Inc. (USA)

11. Fertin Pharma A/S (Denmark)

Table 35: Annual Sales Analysis: 2004-2005 (In DKK million)

12. Final Smoke, Inc. (USA)

13. Glaxosmithkline PLC (UK)

Table 36: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million)

Table 37: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In £ million)

Table 38: Annual Sales Analysis: 2004-2005 (In £ million)

Table 39: Annual Sales Analysis by Segment: 2004-2005 (In £ million)

Glaxosmithkline Consumer Healthcare (UK)

14. Johnson & Johnson (USA)

Table 40: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 41: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 42: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 43: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 44: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 45: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 46: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 47: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Alza Corporation (USA)

15. M.E. Cody Products, Inc. (USA)

16. Nabi Biopharmaceuticals (USA)

Table 48: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 49: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 50: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 51: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 52: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 53: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

17. Native Remedies LLC (USA)

18. Natra Bio (USA)

19. New Sun, Inc. (USA)

20. Nicodrops, Inc. (Canada)

21. Novartis Pharma Switzerland AG (Switzerland)

Novartis Consumer Health, Inc. (USA)

Novartis Holding Japan (Japan)

22. Perrigo Company (USA)

Table 54: First Quarter Sales Analysis: 2006-2007 (In US$ million)

Table 55: First Quarter Sales Analysis by Segment: 2006-2007 (In US$ million)

Table 56: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 57: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 58: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 59: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 60: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

23. Pfizer, Inc. (USA)

Table 61: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ billion)

Table 62: Annual Sales Analysis: 2004-2005 (In US$ billion)

24. Pharmacia K.K. (Japan)

25. Laboratoires Pierre Fabre SA (France)

26. Sanofi-Aventis (France)

Table 63: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In € million)

Table 64: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In € million)

Table 65: Annual Sales Analysis: 2004-2005 (In € million)

Table 66: Annual Sales Analysis by Segment: 2004-2005 (In € million)

Table 67: Annual Sales Analysis by Geographic Region: 2004-2005 (In € million)

27. Sun Pharmaceuticals Industries Ltd. (India)

Table 68: Annual Sales Analysis: 2004-2006 (In INR million)

28. Taisho Pharmaceutical Co. (Japan)

29. Takeda Chemical Industries Ltd. (Japan)

Table 69: Annual Sales Analysis: 2004-2006 (In ¥ billion)

Table 70: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion)

Table 71: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion)

30. Teva Pharmaceutical Industries Ltd. (Israel)

Table 72: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 73: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 74: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 75: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

31. Watson Pharmaceuticals, Inc. (USA)

Table 76: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 77: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 78: Annual Sales Analysis: 2004-2005 (In US$ million)


32. Xenova Group PLC (UK)

Abstract

This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges & tablets, and Others (Nicotine Inhaler, and Nasal Spray). The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 32 companies including many key and niche players worldwide such as GlaxoSmithKline Plc, Johnson & Johnson Inc., Novartis Consumer Healthcare Inc., Perrigo Company, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies (when hard copy is available)is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008